About Theravance
At Theravance Biopharma, Inc., we are working to transform the treatment of serious diseases through the discovery and development of organ-selective medicines designed to maximize patient benefit while minimizing patient risk.
As a spin-off of Theravance, Inc., Theravance Biopharma, Inc. was founded in 2014 and has offices in South San Francisco, and Dublin, Ireland. Our R&D and commercialization strategy is in the areas of inflammation and immunology and our pipeline of internally discovered programs is targeted to address significant patient needs.
We are a place for collaborators and creative problem-solvers – people who thrive on applying insight and innovation to discovering novel medicines.
- Focus : Manufacturer
- Industry : Pharma
Product portfolio of Theravance
News about Theravance
Here you will find Theravance, Inc.
See the theme worlds for related content
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
